Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Total Debt (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Total Debt for 2 consecutive years, with $52.9 million as the latest value for Q4 2025.

  • Quarterly Total Debt rose 742.46% to $52.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.9 million through Dec 2025, up 742.46% year-over-year, with the annual reading at $52.9 million for FY2025, 742.46% up from the prior year.
  • Total Debt for Q4 2025 was $52.9 million at Nuvation Bio, roughly flat from $52.7 million in the prior quarter.
  • The five-year high for Total Debt was $52.9 million in Q4 2025, with the low at $5.7 million in Q1 2025.